# Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/once-weekly-subcutaneous-semaglutide-2-4-mg-injection-is-cost-effective-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hera Sandhu,Weiwei Xu,Anamaria‐Vera Olivieri,Christopher Lübker,Inger Smith,Vasileios Antavalis |
| Citations | 25 |
| DOI | 10.1007/s12325-022-02423-8 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s12325-022-02423-8.pdf |
| OpenAlex ID | https://openalex.org/W4315619447 |
| PMID | 36630047 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Christopher Lübker](https://scholariq.org/researchers/christopher-lubker/)

## Paper journal

- [Advances in Therapy](https://scholariq.org/journals/advances-in-therapy/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.